Regal Investment Advisors »

Alnylam Pharmaceuticals shares owned by Regal Investment Advisors

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Regal Investment Advisors from 13F filings

Historical chart of Regal Investment Advisors investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Regal Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Regal Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $496k 2.8k 177.10
2023-06-30 $531k 2.8k 189.94
2023-03-31 $389k 1.9k 200.32

More positions owned by Regal Investment Advisors

Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Call Call Option (QQQ)
Apple (AAPL)
Ishares Tr Core S&p Ttl Stk (ITOT)
Microsoft Corporation (MSFT)
Fidelity Comwlth Tr Nasdaq Compsit (ONEQ)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Abbvie (ABBV)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Procter & Gamble Company (PG)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Pfd And Incm Sec (PFF)
Johnson & Johnson (JNJ)

View all positions for Regal Investment Advisors

Top funds holding Alnylam Pharmaceuticals

Vanguard Group
BlackRock
Wellington Management Company
Baillie Gifford & Co
Dodge & Cox
T. Rowe Price Associates
Norges Bank Investment Management
Jpmorgan Chase & Co
Susquehanna International
venBio Select Advisor
Legal & General Group
Bellevue Group
Bank of New York Mellon
Ubs Global Asset Management Americas
Amundi

View all funds holding Alnylam Pharmaceuticals